119 related articles for article (PubMed ID: 3522923)
1. GM1 ganglioside counteracts selective neurotoxin-induced lesion of developing serotonin neurons in rat spinal cord.
Fusco M; Donà M; Tessari F; Hallman H; Jonsson G; Gorio A
J Neurosci Res; 1986; 15(4):467-79. PubMed ID: 3522923
[TBL] [Abstract][Full Text] [Related]
2. Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brain.
Jonsson G; Gorio A; Hallman H; Janigro D; Kojima H; Zanoni R
Brain Res; 1984 Nov; 318(2):171-80. PubMed ID: 6093923
[TBL] [Abstract][Full Text] [Related]
3. Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxins.
Jonsson G; Gorio A; Hallman H; Janigro D; Kojima H; Luthman J; Zanoni R
J Neurosci Res; 1984; 12(2-3):459-75. PubMed ID: 6438349
[TBL] [Abstract][Full Text] [Related]
4. Postnatal development of bulbospinal serotoninergic system. effects of GMI ganglioside following neonatal 5,7-dihydroxytryptamine treatment.
Fusco M; Figliomeni B; Gorio A; Vantini G
Neurochem Int; 1988; 13(2):251-9. PubMed ID: 20501295
[TBL] [Abstract][Full Text] [Related]
5. Perinatal morphine treatment inhibits pruning effect and regeneration of serotoninergic pathways following neonatal 5,7-HT lesions.
Gorio A; Di Giulio AM; Germani E; Bendotti C; Bertelli A; Mantegazza P
J Neurosci Res; 1993 Mar; 34(4):462-71. PubMed ID: 8474146
[TBL] [Abstract][Full Text] [Related]
6. The effects of exogenous GM1 ganglioside on neurotoxin induced damage of cerebral serotonin nerve terminals in adult rats.
Kojima H; Yamada S; Yokoo H; Tsutsumi T; Nishi S; Inanaga K; Nagatsu I; Jonsson G; Toffano G
Kurume Med J; 1988; 35(2):49-61. PubMed ID: 2461463
[No Abstract] [Full Text] [Related]
7. Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-OHDA), 5,6-dihydroxytryptamine (5,6-DHT) or repeated monoamine administration.
Howe JR; Yaksh TL
J Pharmacol Exp Ther; 1982 Feb; 220(2):311-21. PubMed ID: 6120226
[TBL] [Abstract][Full Text] [Related]
8. The serotoninergic bulbospinal system and brainstem-spinal cord content of serotonin-, TRH-, and substance P-like immunoreactivity in the aged rat with special reference to the spinal cord motor nucleus.
Johnson H; Ulfhake B; Dagerlind A; Bennett GW; Fone KC; Hökfelt T
Synapse; 1993 Sep; 15(1):63-89. PubMed ID: 7508641
[TBL] [Abstract][Full Text] [Related]
9. Postnatal development of brainstem serotonin-containing neurons projecting to lumbar spinal cord in rats.
Tanaka H; Amamiya S; Miura N; Araki A; Ohinata J; Fujieda K
Brain Dev; 2006 Oct; 28(9):586-91. PubMed ID: 16730936
[TBL] [Abstract][Full Text] [Related]
10. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
Bervoets K; Rivet JM; Millan MJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
[TBL] [Abstract][Full Text] [Related]
11. Effect of substance P on the 5,7-dihydroxytryptamine induced alteration of the postnatal development of central serotonin neurons.
Jonsson G; Hallman H
Med Biol; 1983 Apr; 61(2):105-12. PubMed ID: 6192293
[TBL] [Abstract][Full Text] [Related]
12. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
Kirby ML; Mattio TG
Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
[TBL] [Abstract][Full Text] [Related]
13. The neuroprotective effects of NGF combined with GM1 on injured spinal cord neurons in vitro.
Huang F; Dong X; Zhang L; Zhang X; Zhao D; Bai X; Li Z
Brain Res Bull; 2009 Apr; 79(1):85-8. PubMed ID: 19133317
[TBL] [Abstract][Full Text] [Related]
14. Urine retention due to intra-spinal cord injection of colchicine in rats: improved recovery of bladder function by monosialoganglioside GM1 and nerve growth factor administration.
Baraldi M; Zanoli P; Truzzi C; Paro M; Italiano G; Prosdocimi M
Funct Neurol; 1991; 6(3):235-8. PubMed ID: 1743534
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological action of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-banzazonine). (II) Relationship between the analgesic action of eptazocine and brain 5-hydroxytryptamine (5-HT) (author's transl)].
Kameyama T; Nabeshima T; Yamaguchi K; Kamata K; Ukai M; Okuyama S; Sakakibara S
Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):613-27. PubMed ID: 6174403
[TBL] [Abstract][Full Text] [Related]
16. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury.
Oatway MA; Chen Y; Weaver LC
Pain; 2004 Jul; 110(1-2):259-68. PubMed ID: 15275776
[TBL] [Abstract][Full Text] [Related]
18. Serotonin refines the locomotor-related alternations in the in vitro neonatal rat spinal cord.
Pearlstein E; Ben Mabrouk F; Pflieger JF; Vinay L
Eur J Neurosci; 2005 Mar; 21(5):1338-46. PubMed ID: 15813943
[TBL] [Abstract][Full Text] [Related]
19. Lesioning and recovery of the serotoninergic hippocampal afferents: differential effects of GM1 ganglioside.
Lombardi G; Beni M; Consolazione A; Moroni F
Neuropharmacology; 1988 Nov; 27(11):1085-8. PubMed ID: 2462696
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats.
Garofalo L; Cuello AC
Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
